Your browser doesn't support javascript.
loading
The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.
Smith Byrne, K; Appleby, P N; Key, T J; Holmes, M V; Fensom, G K; Agudo, A; Ardanaz, E; Boeing, H; Bueno-de-Mesquita, H B; Chirlaque, M D; Kaaks, R; Larrañaga, N; Palli, D; Perez-Cornago, A; Quirós, J R; Ricceri, F; Sánchez, M J; Tagliabue, G; Tsilidis, K K; Tumino, R; Fortner, R T; Ferrari, P; Riboli, E; Lilja, H; Travis, R C.
Afiliación
  • Smith Byrne K; Cancer Epidemiology Unit.
  • Appleby PN; Cancer Epidemiology Unit.
  • Key TJ; Cancer Epidemiology Unit.
  • Holmes MV; Medical Research Council Population Health Research Unit, University of Oxford, Oxford; Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Oxford; National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospital, Oxford; Medical Research Counci
  • Fensom GK; Cancer Epidemiology Unit. Electronic address: georgina.fensom@ndph.ox.ac.uk.
  • Agudo A; Unit of Nutrition and Cancer, Catalan Institute of Oncology-IDIBELL, Barcelona.
  • Ardanaz E; CIBER of Epidemiology and Public Health (CIBERESP), Madrid; Navarra Public Health Institute, Pamplona; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Boeing H; Department of Epidemiology, German Institute of Human Nutrition (DIfE), Potsdam-Rehbrücke, Germany.
  • Bueno-de-Mesquita HB; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Epidemiology and Biostatistics, Imperial College London, London, UK; Department of Social & Preventive Medicine, Faculty of Medicine,
  • Chirlaque MD; CIBER of Epidemiology and Public Health (CIBERESP), Madrid; Department of Epidemiology, IMIB-Arrixaca, Murcia; Department of Health and Social Sciences, University of Murcia, Murcia, Spain.
  • Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Larrañaga N; CIBER of Epidemiology and Public Health (CIBERESP), Madrid; Public Health Division of Gipuzkoa, Regional Government of the Basque Country, Vitoria-Gasteiz, Spain.
  • Palli D; Cancer Risk Factors and Life-style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • Perez-Cornago A; Cancer Epidemiology Unit.
  • Quirós JR; Public Health Directorate, Asturias, Spain.
  • Ricceri F; Unit of Epidemiology, Regional Health Service Azienda Sanitaria Locale Torino 3 (ASL TO3), Grugliasco; Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Sánchez MJ; CIBER of Epidemiology and Public Health (CIBERESP), Madrid; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
  • Tagliabue G; Department of Preventative and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tsilidis KK; Department of Epidemiology and Biostatistics, Imperial College London, London, UK; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Tumino R; Cancer Registry and Histopathology Unit, "Civic M.P. Arezzo" Hospital, Ragusa, Italy.
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ferrari P; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Riboli E; Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
  • Lilja H; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medicine, Memorial Sloan Kettering Cancer
  • Travis RC; Cancer Epidemiology Unit.
Ann Oncol ; 30(6): 983-989, 2019 06 01.
Article en En | MEDLINE | ID: mdl-31089709
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas de Secreción Prostática Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas de Secreción Prostática Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article